Quarterly report · Q2
4272.TEDINET S100S30O
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥97.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥198.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥102.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥4.8bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥13.6bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥8.3bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥23.0bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.6bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥8.8bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥16.4bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥6.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥15.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥6.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥349.2bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥322.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥329.5bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥81.7bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥67.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥267.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥255.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥259.2bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥50.5bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥48.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥57.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥52.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥20.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥12.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥15.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥9.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥2.3bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥36.74 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.69 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.36 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.04 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.63 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥36.72 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥89.33 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥67.02 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 76.3% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.4% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥78m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥78m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥3.9bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥28.0bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥27.9bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥77m |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥30.5bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥30.5bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥0 |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥39.5bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥39.5bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥98.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥97.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥78m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥8.7bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥82m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥82m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥3.7bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥36.7bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥36.6bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥82m |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥7.2bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥30.0bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥30.0bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥5.4bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥36.2bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥36.2bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥102.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥102.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥82m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥17.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 573
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and deposits | CurrentQuarterInstant | 50536000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 53550000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 59889000000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 2004000000 | JPY |
| Electronically recorded monetary claims operating ca | CurrentQuarterInstant | 2716000000 | JPY |
| Short term investment securities | Prior1YearInstant | 6296000000 | JPY |
| Short term investment securities | CurrentQuarterInstant | 7820000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 46217000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 44283000000 | JPY |
| Work in process | Prior1YearInstant | 1130000000 | JPY |
| Work in process | CurrentQuarterInstant | 1471000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 23759000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 24904000000 | JPY |
| Other ca | Prior1YearInstant | 5072000000 | JPY |
| Other ca | CurrentQuarterInstant | 6366000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -44000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -165000000 | JPY |
| Current assets | Prior1YearInstant | 186037000000 | JPY |
| Current assets | CurrentQuarterInstant | 197824000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 42544000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 43453000000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 26069000000 | JPY |
| Machinery equipment and vehicles net | CurrentQuarterInstant | 27023000000 | JPY |
| Other net ppe | Prior1YearInstant | 20644000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 22850000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 89259000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 93326000000 | JPY |
| Goodwill | Prior1YearInstant | 2492000000 | JPY |
| Goodwill | CurrentQuarterInstant | 2239000000 | JPY |
| Other ia | Prior1YearInstant | 4047000000 | JPY |
| Other ia | CurrentQuarterInstant | 3881000000 | JPY |
| Intangible assets | Prior1YearInstant | 6539000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 6120000000 | JPY |
| Investment securities | Prior1YearInstant | 32146000000 | JPY |
| Investment securities | CurrentQuarterInstant | 42657000000 | JPY |
| Net defined benefit asset | Prior1YearInstant | 3845000000 | JPY |
| Net defined benefit asset | CurrentQuarterInstant | 3934000000 | JPY |
| Other ioa | Prior1YearInstant | 5084000000 | JPY |
| Other ioa | CurrentQuarterInstant | 5439000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -54000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -54000000 | JPY |
| Investments and other assets | Prior1YearInstant | 41021000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 51976000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 136820000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 151423000000 | JPY |
| Assets | Prior1YearInstant | 322858000000 | JPY |
| Assets | CurrentQuarterInstant | 349247000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 16239000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 21010000000 | JPY |
| Short term loans payable | Prior1YearInstant | 3380000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |